Loading...
Rising Regulatory Hurdles And US Tariffs Will Undermine Biosimilar Margins
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
52.5%7D
-4.2%1Y
52.5%7D
-4.2%You can edit this narrative until Aug 25 10:25 PM. Then, changes will post as Updates.